Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ATYRATYR
24 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ATYR PHARMA INC

CITADEL ADVISORS LLC holds 1.2M shares of ATYR (ATYR PHARMA INC), worth $741,265 as of 2026-Q2. The position was increased (+2521.9% shares). ATYR represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$741,265

Current Shares

1.2M

Total Value Change

+$684,265

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+2521.9%
$741,2650.0%$0.60
40
2026-Q1
New
47,372
-
$36,9500.0%$0.96
31
2025-Q3
Exited
0
-100.0%
$00.0%$0.80
0
2025-Q2
Decreased
119,117
-54.4%
$603,9230.0%$5.03
0
2025-Q1
Increased
261,007
+2011.5%
$788,2410.0%$3.13
40
2024-Q4
Decreased
12,361
-98.7%
$44,7470.0%$3.51
0
2024-Q3
Decreased
966,607
-47.6%
$1.7M0.0%$1.77
0
2024-Q2
Decreased
1.8M
-3.0%
$2.9M0.0%$1.56
0
2024-Q1
Increased
1.9M
+8.5%
$3.7M0.0%$1.95
29
2023-Q4
Decreased
1.8M
-1.7%
$2.5M0.0%$1.41
0
2023-Q3
Increased
1.8M
+457.4%
$2.8M0.0%$1.58
42
2023-Q2
Increased
320,090
+682.1%
$691,3940.0%$2.12
40
2023-Q1
Increased
40,929
+8.2%
$85,9510.0%$2.10
16
2022-Q4
New
37,837
-
$82,8630.0%$2.19
33
2022-Q2
Exited
0
-100.0%
$00.0%$2.75
0
2022-Q1
Decreased
159,921
-17.4%
$855,0000.0%$5.45
0
2021-Q4
Decreased
193,494
-3.5%
$1.4M0.0%$7.50
0
2021-Q3
Increased
200,415
+570.9%
$1.8M0.0%$8.87
42
2021-Q2
Increased
29,873
+121.8%
$145,0000.0%$4.78
25
2021-Q1
New
13,470
-
$60,0000.0%$4.39
32
2020-Q3
Exited
0
-100.0%
$00.0%$3.27
0
2020-Q2
Decreased
11,998
-35.5%
$53,0000.0%$4.58
0
2020-Q1
Increased
18,605
+35.1%
$52,0000.0%$2.87
18
2019-Q4
New
13,774
-
$57,0000.0%$4.17
32

Other major holders of ATYR: FEDERATED HERMES, INC., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used